Hims & Hers Health, Inc. revised earnings guidance for the year 2022. For the full year, the company is raising revenue outlook to between $470 million and $485 million, which represents year-over-year growth of between 73% and 78%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.9 USD | -3.57% | -14.76% | +33.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.71% | 2.64B | |
-39.77% | 2.23B | |
+23.62% | 502M | |
+42.77% | 467M | |
-63.32% | 153M |
- Stock Market
- Equities
- HIMS Stock
- News Hims & Hers Health, Inc.
- Hims & Hers Health, Inc. Revises Earnings Guidance for the Year 2022